A detailed history of Putnam Investments LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Putnam Investments LLC holds 699,432 shares of NEO stock, worth $11.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
699,432
Previous 367,579 90.28%
Holding current value
$11.6 Million
Previous $4.52 Million 150.3%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $3.87 Million - $6.88 Million
331,853 Added 90.28%
699,432 $11.3 Million
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $4.47 Million - $6.56 Million
367,579 New
367,579 $4.52 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.08B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.